BioSyent (BIOYF) Stock Price, News & Analysis

Company Overview

BioSyent Inc. is a specialty biopharmaceutical company focused on developing, manufacturing and commercializing pharmaceutical products and medical devices. The company leverages expertise in regulatory affairs, clinical development and manufacturing to deliver a range of branded and generic therapies across multiple therapeutic areas, with particular emphasis on endocrine disorders, supportive care oncology and dermatology.

BioSyent operates a manufacturing facility in Canada that supports both its proprietary portfolio and contract development and manufacturing services (CDMO) for small-molecule products. Its end-to-end capabilities—encompassing formulation, fill-finish and quality testing—serve clients in North America and selected international markets.

The company's commercial footprint spans Canada and the United States, where it markets specialty pharmaceuticals through its dedicated sales force and distribution partnerships. BioSyent continues to bolster its product pipeline through strategic in-licensing, acquisitions and targeted internal development programs, aiming to address evolving patient needs in niche therapeutic segments.

Guided by an experienced leadership team with backgrounds in pharmaceutical development and commercialization, BioSyent is focused on sustainable growth through portfolio expansion and manufacturing capacity enhancement. The company's strategy emphasizes high-value specialty products, positioning BioSyent to respond to emerging healthcare trends and regulatory opportunities.

Key Stats

• Today's Range: $10.89 to $10.89
• 50-Day Range: $9.76 to $11.02
• 52-Week Range: $7.63 to $12.00
• Volume: 40 shs
• Average Volume: 2,680 shs
• Market Capitalization: N/A
• P/E Ratio: 53.49
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

Company Calendar

• Today: 8/17/2026
• Next Earnings (Estimated): 8/20/2026

Industry, Sector and Symbol

• Stock Exchange: OTCMKTS
• Sector: Healthcare
• Industry: Pharmaceuticals
• Sub-Industry: Pharmaceuticals
• Current Symbol: OTCMKTS:BIOYF
• CIK: N/A
• Web: www.biosyent.com
• Phone: (905) 206-0013
• Fax: N/A
• Employees: N/A
• Year Founded: N/A

Profitability

• EPS (Trailing Twelve Months): N/A
• Trailing P/E Ratio: 53.49
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: N/A
• Quick Ratio: N/A

Sales & Book Value

• Annual Sales: N/A
• Price / Sales: N/A
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: N/A
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: N/A
• Free Float: N/A
• Market Cap: N/A
• Optionable: Not Optionable
• Beta: N/A